Indaptus Therapeutics, Inc. financial data

Symbol
INDP on Nasdaq
Location
3 Columbus Circle, 15 Th Floor, New York, NY
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 12, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 146 % -68.6%
Debt-to-equity 36 % +155%
Return On Equity -697 % -293%
Return On Assets -255 % -81%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.75M shares -82.8%
Common Stock, Shares, Outstanding 1.64M shares -83.9%
Entity Public Float 15M USD +13.2%
Common Stock, Value, Issued 16.4K USD -83.9%
Weighted Average Number of Shares Outstanding, Basic 997K shares +194%
Weighted Average Number of Shares Outstanding, Diluted 997K shares +194%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 8.98M USD +31.9%
General and Administrative Expense 6.87M USD -19.8%
Operating Income (Loss) -15.8M USD -3.09%
Nonoperating Income (Expense) 247K USD -72.2%
Net Income (Loss) Attributable to Parent -16.9M USD -13.3%
Earnings Per Share, Basic 8 USD/shares +67%
Earnings Per Share, Diluted 8 USD/shares +67%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 5.83M USD -21.1%
Marketable Securities, Current 6.99M USD -62.7%
Assets, Current 6.44M USD -15.6%
Property, Plant and Equipment, Net 735 USD -63.6%
Operating Lease, Right-of-Use Asset 8.49K USD -92%
Other Assets, Noncurrent 393K USD -22.2%
Assets 6.84M USD -17%
Accounts Payable, Current 707K USD +27.2%
Employee-related Liabilities, Current 43.4K USD -95.4%
Liabilities, Current 2.23M USD +0.08%
Operating Lease, Liability, Noncurrent 4.01K USD -95.8%
Liabilities 3.39M USD +19.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax 134K USD
Retained Earnings (Accumulated Deficit) -73.2M USD -30%
Stockholders' Equity Attributable to Parent 4.61M USD -23.3%
Liabilities and Equity 6.84M USD -17%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -5.05M USD -28.2%
Net Cash Provided by (Used in) Financing Activities 3.15M USD +897%
Net Cash Provided by (Used in) Investing Activities 2.14M USD
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 1.64M shares -83.9%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Deferred Tax Assets, Valuation Allowance 56.9M USD +4.5%
Deferred Tax Assets, Gross 57M USD +4.47%
Operating Lease, Liability 8.69K USD -92%
Depreciation 735 USD +129%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -15M USD +3.21%
Lessee, Operating Lease, Liability, to be Paid 8.69K USD -92.3%
Operating Lease, Liability, Current 8.69K USD -91.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 86.9K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 86.9K USD -14.6%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 372 USD -94.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 86.9K USD
Deferred Tax Assets, Operating Loss Carryforwards 53.4M USD +3.09%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares
Operating Lease, Payments 26.1K USD +3%
Additional Paid in Capital 77.8M USD +25%
Preferred Stock, Shares Outstanding 0 shares
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares